A new era of disease management is here with approval by the US Food and Drug Administration and European Commission of the first disease-specific therapy for metabolic-associated steatohepatitis (MASH). This activity will explore how thyroid hormone receptor- (THR- ) agonists can improve fibrosis and reduce disease progression in patients with MASH, using real-world case scenarios. Recent advances and guideline recommendations in screening and noninvasive screening will be presented along with best practices for optimizing guideline-recommended disease-directed therapy.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
CME included with membership
| Virtual Course (Foundations of Aesthetic Medicine) | C$749 |
| In-Person Hands-On Training (Foundations of Aesthetic Medicine) | C$4,995 |
Collected from the provider’s public pages · source
Specialties served/covered
- Addiction Medicine
- Addiction Psychiatry
- Cardiovascular Disease
- Child & Adolescent Psychiatry
- Clinician Wellness & Burnout
- Communication & Shared Decision-Making
- Dermatology
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Facial Plastic & Reconstructive Surgery
- Family Medicine
- Female Pelvic Medicine & Reconstructive Surgery
- Gastroenterology
- General & Adult Psychiatry
- General Internal Medicine
- General Operative Anesthesia
- General Otolaryngology
- General Pediatrics
- General Surgery
- Health Equity & Inclusion
- Hematology
- Hospice & Palliative Medicine
- Hospital Medicine
- Infectious Disease
- Medical Genetics & Genomics
- Medical Oncology
- Medical Toxicology
- Mood & Anxiety Disorders
- Nephrology
- Neurology
- Neuromuscular Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedic Surgery
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Gastroenterology
- Pediatric Neurology
- Physical Medicine & Rehabilitation
- Plastic & Reconstructive Surgery
- Practice Management & Ethics
- Primary Care Sports Medicine
- Psychopharmacology
- Pulmonary Disease
- Rheumatology
- Rhinology
- Sleep Medicine
- Thoracic Surgery
- Transplant Hepatology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Rehabilitation
- Sports & Exercise Medicine
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedNov 15, 2025
-
Last day to claim creditNov 16, 2026 5 weeks left
-
Catalyst Medical Education, LLC +1 A New Era in MASH: How Disease-Specific Therapies Are Changing the Game and Best Practices for Clinical Integration
-
Catalyst Medical Education, LLC +1 MASH Management in the Era of Disease-Specific Therapies: Implementing Screen, Stage, Treat Paradigms in Clinical Practice
-
Revelar Health LLC. +1 Fatty Liver Case Rounds Real-World Treatment Plans That Work
-
PRIME Education, Inc. (PRIME®) Keeping Pace in a New Era of MASH: Navigating the Latest Treatment Guidance and Novel Therapies
-
Learner’s Digest International (TM) Selective Thyroid Hormone Receptor-Beta Agonists for Metabolic Dysfunction-associated Steatohepatitis (MASH)
-
Medscape, LLC Managing Metabolic Dysfunction-Associated Steatohepatitis in Practice: A Virtual Patient Simulation Exercise
